BRD-K63516691-003-01-2 (Substance)

Compound:

Methyl 2-[(2-methylpyridin-4-yl)methyl]-1-oxo-8-(pyrimidin-2-ylmethoxy)-4-(3,4,5-trimethoxyphenyl)-1,2-dihydro-2,7-naphthyridine-3-carboxylate

Compound (Entity type)

Synonyms:BRD-K63516691-003-01-2

Id:375178215

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View BRD-K63516691-003-01-2's neighborhood in the knowledge graph.

Submit

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 MOAR010 MELHO 24H N05 T-0156 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC CPC016 MCF7 24H B11 T-0156 10.00um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase1 project
	L1000 LINCS DCIC MUC.CP006 MCF7 6H B21 T-0156 1.11um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase1 project
	L1000 LINCS DCIC 2021 MOAR010 MDAMB468 24H N06 T-0156 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR006 A375 24H D14 T-0156 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC MUC.CP006 MCF7 24H B22 T-0156 0.37um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase1 project
	L1000 LINCS DCIC 2021 MOAR010 CAL29 24H N06 T-0156 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR010 IGR37 24H N05 T-0156 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR010 IGR37 24H N06 T-0156 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR010 OVTOKO 24H N06 T-0156 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 MOAR010 MELHO 24H N05 T-0156 3.33uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC CPC016 MCF7 24H B11 T-0156 10.00um

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase1 project

L1000 LINCS DCIC MUC.CP006 MCF7 6H B21 T-0156 1.11um

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase1 project

L1000 LINCS DCIC 2021 MOAR010 MDAMB468 24H N06 T-0156 1.11uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 MOAR006 A375 24H D14 T-0156 3.33uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC MUC.CP006 MCF7 24H B22 T-0156 0.37um

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase1 project

L1000 LINCS DCIC 2021 MOAR010 CAL29 24H N06 T-0156 1.11uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 MOAR010 IGR37 24H N05 T-0156 3.33uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 MOAR010 IGR37 24H N06 T-0156 1.11uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 MOAR010 OVTOKO 24H N06 T-0156 1.11uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.